Afynia Laboratories Announces $2M to Bring Endometriosis Test to Market

Led by two former McMaster University research scientists with experience in women’s health, Hamilton, Ontario’s Afynia Laboratories has set out to improve how endometriosis is diagnosed. Afynia closed a $2-million CAD round of pre-seed funding to develop and begin bringing their innovative solution, EndomiR, to market.

Afynia Laboratories is an alumnus of our WiHI program and presented at the OBIO® Investment Summit.

Previous
Previous

MOLLI Surgical Acquired by Stryker

Next
Next

Luxsonic Launches First Canadian Radiology Application for Apple Vision Pro